Emma Brouwer

Emma Brouwer has been approved to participate in a new drug trial designed to reduce the recurrence rate of TNBC (triple-negative breast cancer).  She will receive the first of three doses on Thursday, July 16.  Please pray that the Lord uses this medication to provide ongoing health and strength.